WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Behavioral: Stretching
Behavioral: Treadmill
Behavioral: Tango

First Posted Date: 2013-01-15

Last Posted Date: 2018-11-19

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 119

Registration Number: NCT01768832

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Weight Management in Obese Pregnant Underserved African American Women

Not Applicable

Completed

Conditions: Pregnancy
Obesity
Weight Gain

Interventions: Behavioral: Standard Parents As Teachers (PAT)
Behavioral: Parents As Teachers Plus (PAT+)

First Posted Date: 2013-01-15

Last Posted Date: 2018-02-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 267

Registration Number: NCT01768793

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics

Phase 1

Terminated

Conditions: Surgical Site Infection

Interventions: Drug: Intrasite Vancomycin
Drug: IV Vancomycin

First Posted Date: 2013-01-10

Last Posted Date: 2018-05-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT01764750

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

Phase 2

Recruiting

Conditions: Alzheimers Disease
Dementia
Alzheimers Disease, Familial

Interventions: Drug: Gantenerumab
Drug: Solanezumab
Drug: Matching Placebo (Gantenerumab)
Drug: Matching Placebo (Solanezumab)
Drug: E2814
Drug: Lecanemab
Drug: Matching Placebo (E2814)

First Posted Date: 2013-01-03

Last Posted Date: 2024-07-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 490

Registration Number: NCT01760005

Locations: 🇨🇦
UBC Hospital, Vancouver, British Columbia, Canada
🇺🇸
University of Washington, Seattle, Washington, United States
🇫🇷
CHU de Rouen - Hôpital Charles Nicolle, Rouen, Seine Maritime, France

and more 35 locations

LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer

Phase 2

Withdrawn

Conditions: Breast Neoplasms

Interventions: Drug: Placebo
Drug: Erismodegib

First Posted Date: 2012-12-28

Last Posted Date: 2015-04-27

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01757327

Calorie Restriction With Leucine Supplementation

Not Applicable

Completed

Conditions: Osteoporosis
Menopause
Sarcopenia
Obesity

Interventions: Behavioral: Weight loss with normal protein and leucine intake
Behavioral: Weight loss with protein/leucine supplementation

First Posted Date: 2012-12-28

Last Posted Date: 2017-03-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 43

Registration Number: NCT01757340

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings

Not Applicable

Completed

Conditions: Leukemia
Lymphoma
Paraproteinemias
Multiple Myeloma
Myelodysplastic Syndromes

Interventions: Procedure: USCOM scan
Procedure: Fluid Bolus

First Posted Date: 2012-12-21

Last Posted Date: 2013-09-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 69

Registration Number: NCT01755000

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Can Fish Oil and Phytochemical Supplements Mimic Anti-Aging Effects of Calorie Restriction?

Not Applicable

Completed

Conditions: Healthy Volunteers

Interventions: Dietary Supplement: Supplement

First Posted Date: 2012-12-19

Last Posted Date: 2012-12-19

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 56

Registration Number: NCT01752868

Locations: 🇺🇸
Washington University Medical Center, St. Louis, Missouri, United States

Lipid Biomarkers for Diabetic Heart Disease

Not Applicable

Completed

Conditions: Type II Diabetes Mellitus
Diabetes Complications

Interventions: Drug: Placebo for fenofibrate
Drug: Fenofibrate

First Posted Date: 2012-12-19

Last Posted Date: 2019-03-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 70

Registration Number: NCT01752842

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

Phase 1

Terminated

Conditions: Leukemia, Myeloid, Acute
Myelodysplastic Syndromes
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions: Drug: Azacitidine

First Posted Date: 2012-12-11

Last Posted Date: 2019-10-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 54

Registration Number: NCT01747499

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy